An Expanded Access Protocol for a Single Subject Who Has Completed 24-Weeks of Treatment in PR0140_CD02 Study

NO_LONGER_AVAILABLE

Conditions studied: HIV

In brief

The primary objective is to provide continued access to PRO 140 to a subject who has completed participation in PRO140\_CD02.

Key facts

Study ID

NCT02759042

Run by

CytoDyn, Inc.

Last updated by the study team

2018-03-13

Who can join

Age: 55 and older, up to 56. Sex: male. Healthy volunteers: not accepted.

Where it is running

• CD02 EA Investigational site — Orlando, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.